Johns Hopkins Coronavirus Resource Center. https://coronavirus.jhu.edu/(online access: 16/08/2020)
Blocking information on COVID-19 can fuel the spread of misinformation.
Nature. 2020; 580 (): 306
The online competition between pro- and anti-vaccination views.
Nature. 2020;
Scientists are drowning in COVID-19 papers. Can new tools keep them afloat?.
Science. 2020;
Strengthening the Reporting of Observational Studies in Epidemiology for respondent-driven sampling studies: “STROBE-RDS” statement.
J Clin Epidemiol. 2015;
Speed Science: The risks of swiftly spreading coronavirus research.
Reuters. 2020;
Adverse Consequences of Rushing a SARS-CoV-2 Vaccine: Implications for Public Trust.
Jama. 2020;
Reliable assessment of the effects of treatment on mortality and major morbidity, I: clinical trials.
Lancet. 2001; 357: 373-380
Which clinical studies provide the best evidence? The best RCT still trumps the best observational study.
Bmj. 2000; 321: 255-256
Association is not causation: treatment effects cannot be estimated from observational data in heart failure.
Eur Heart J. 2018; 39: 3417-3438
Small studies: strengths and limitations.
in: Eur Respir J. 32. 2008: 1141-1143 ()
Media Coverage, Journal Press Releases and Editorials Associated with Randomized and Observational Studies in High-Impact Medical Journals: A Cohort Study.
PLoS One. 2015; 10e0145294
Head to head comparison of the propensity score and the high-dimensional propensity score matching methods.
BMC Med Res Methodol. 2016; 16: 22
The design versus the analysis of observational studies for causal effects: parallels with the design of randomized trials.
Stat Med. 2007; 26: 20-36
Big data and large sample size: a cautionary note on the potential for bias.
Clin Transl Sci. 2014; 7: 342-346
Making inferences on treatment effects from real world data: propensity scores, confounding by indication, and other perils for the unwary in observational research.
Bmj. 2013; 347: f6409
Bias and causal associations in observational research.
Lancet. 2002; 359: 248-252
Discussing hidden bias in observational studies.
Ann Intern Med. 1991; 115: 901-905
Avoidable flaws in observational analyses: an application to statins and cancer.
Nat Med. 2019; 25: 1601-1606
Win-Win: Reconciling Social Epidemiology and Causal Inference.
Am J Epidemiol. 2020; 189: 167-170
Hazard ratios in cancer clinical trials–a primer.
Nat Rev Clin Oncol. 2012; 9 (): 178-183
Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19.
N Engl J Med. 2020;
Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19.
N Engl J Med. 2020;
On the use of corticosteroids for 2019-nCoV pneumonia.
Lancet. 2020; 395: 683-684
Baricitinib as potential treatment for 2019-nCoV acute respiratory disease.
Lancet. 2020; 395: e30-e31
Association of Treatment With Hydroxychloroquine or Azithromycin With In-Hospital Mortality in Patients With COVID-19 in New York State.
Jama. 2020;
Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma.
Jama. 2020;
Use of Prone Positioning in Nonintubated Patients With COVID-19 and Hypoxemic Acute Respiratory Failure.
Jama. 2020;
Compassionate Use of Remdesivir for Patients with Severe Covid-19.
N Engl J Med. 2020;
Respiratory Parameters in Patients With COVID-19 After Using Noninvasive Ventilation in the Prone Position Outside the Intensive Care Unit.
Jama. 2020;
Use of renin-angiotensin-aldosterone system inhibitors and risk of COVID-19 requiring admission to hospital: a case-population study.
Lancet. 2020;
Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis.
Lancet. 2020;
Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial.
Lancet. 2020;
Understanding Observational Treatment Comparisons in the Setting of Coronavirus Disease 2019 (COVID-19).
JAMA Cardiol. 2020;
Association of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use With COVID-19 Diagnosis and Mortality.
Jama. 2020; 324: 168-177
A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19.
N Engl J Med. 2020; 382: 1787-1799
Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial.
Lancet. 2020;
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial.
Lancet. May 16, 2020; 395: 1569-1578
Remdesivir for the Treatment of Covid-19 — Preliminary Report.
NEJM. 2020;
Remdesivir for 5 or 10 Days in Patients with Severe Covid-19.
N Engl J Med. 2020;
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19.
N Engl J Med. 2020;
Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19: A Randomized Clinical Trial.
Jama. 2020;
Dexamethasone in Hospitalized Patients with Covid-19 – Preliminary Report.
N Engl J Med. 2020;
signatories, J. W. o. t. b. o., An open letter to Mehra et al and The Lancet. 2020.
Hydroxychloroquine or Chloroquine for Treatment or Prophylaxis of COVID-19: A Living Systematic Review.
Ann Intern Med. 2020;
COVID-19 coronavirus research has overall low methodological quality thus far: case in point for chloroquine/hydroxychloroquine.
J Clin Epidemiol. 2020;
Improving Clinical Trial Enrollment – In the Covid-19 Era and Beyond.
N Engl J Med. 2020;
Research in the Context of a Pandemic.
N Engl J Med. 2020;
An organizational analysis of the World Health Organization: narrowing the gap between promise and performance.
Soc Sci Med. 1995; 40: 731-742
WHO’s Next – The United States and the World Health Organization.
N Engl J Med. 2020;
New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?.
Int J Antimicrob Agents. 2020; 105938
Global regulators work towards alignment on policy approaches and regulatory flexibility during COVID-19 – update #3. https://www.ema.europa.eu/en/news/global-regulators-work-towards-alignment-policy-approaches-regulatory-flexibility-during-covid-19-2(online access: 16/08/2020).
Counteracting Health Misinformation: A Role for Medical Journals?.
Jama. 2019; 321: 1863-1864
Addressing Health-Related Misinformation on Social Media.
Jama. 2018; 320: 2417-2418
Protecting the Value of Medical Science in the Age of Social Media and “Fake News”.
Jama. 2018; 320: 2415-2416
The spread of true and false news online.
Science. 2018; 359: 1146-1151
In India, Hindu pride boosts pseudoscience.
Science. 2019; 363 (): 679-680
Weaponized Health Communication: Twitter Bots and Russian Trolls Amplify the Vaccine Debate.
Am J Public Health. 2018; 108: 1378-1384
Medical Education in the Era of Alternative Facts.
N Engl J Med. 2017; 377: 607-609
Infographic: The Best And Worst Science News Sites.
American Council on Science and Health. 2017;
Roth, Y.; Achuthan, A., Building rules in public: Our approach to synthetic & manipulated media. https://blog.twitter.com/en_us/topics/company/2020/new-approach-to-synthetic-and-manipulated-media.html(online access: 16/08/2020).
Predicting social response to infectious disease outbreaks from internet-based news streams.
Ann Oper Res. 2018; 263 : 551-564
Medical Misinformation: Vet the Message!.
Eur Heart J. 2019; 40: 404-405
Grading quality of evidence and strength of recommendations.
Bmj. 2004; 328: 1490
Twitter promotion predicts citation rates of cardiovascular articles: a preliminary analysis from the ESC Journals Randomized Study.
Eur Heart J. 2020;
Twitter-based learning for continuing medical education?.
Eur Heart J. 2020;
Nudge: Improving Decisions about Health, Wealth, and Happiness.
2008
Citation analysis may severely underestimate the impact of clinical research as compared to basic research.
PLoS One. 2013; 8: e62395
Moderna Announces Positive Interim Phase 1 Data for its mRNA Vaccine (mRNA-1273) Against Novel Coronavirus. https://investors.modernatx.com/news-releases/news-release-details/moderna-announces-positive-interim-phase-1-data-its-mrna-vaccine/(online access: 16/08/2020).
In Race for a Coronavirus Vaccine, an Oxford Group Leaps Ahead. https://www.nytimes.com/2020/04/27/world/europe/coronavirus-vaccine-update-oxford.html(online access: 16/08/2020).
Haseltine, W.Rush to share good news on COVID-19 drugs is undermining science. https://www.washingtonpost.com/opinions/2020/05/19/rush-share-good-news-covid-19-drugs-is-undermining-science/(online access: 16/08/2020).